An attempt was made to use one resolute onyx coronary drug eluting stent (des) to treat a non-tortuous, non-calcified lesion located in the mid posterior tibial artery.The device was not inspected.Negative prep was performed with no issues.The lesion was pre-dilated.The device did not pass through a previously deployed stent.Resistance was not encountered when advancing the device.Excessive force was not used during delivery.It was reported that a balloon burst or leak occurred during stent deployment. nominal pressure was applied prior to the burst or leak, but the balloon would not inflate.Two inflations were applied to the device prior to the issue.It is believed that there was a pin size hole in the balloon of the stent.The patient is alive with no injury.
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
Additional information: the lesion had 10% stenosis.It was later confirmed, that a balloon burst did not occur.However, inflation issues occurred, on the first inflation on the balloon.And the first inflation never reached the minimum pressure. there was only partial inflation of the balloon.The device was not moved or repositioned, while inflated.The same inflation device was successfully used with other devices.The stent was implanted and needed to be post-dilated with another balloon.The patient is alive with no further injury.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank, because the information is currently, unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|